Table 2.
RE | RA | |||
---|---|---|---|---|
|
|
|||
DXA | NMR | DXA | NMR | |
Low-weight (n=10) | ||||
FM (CV) | 5.63±2.90 | 27.03±14.69 | 6.92±4.72 | 19.69±13.08 |
LM (CV) | 0.36±0.21 | 6.11±2.17 | 0.44±0.32 | 2.75±1.93 |
BMC (CV) | 3.51±1.56 | NA | 3.51±1.56 | NA |
| ||||
Mid-weight (n=10) | ||||
FM (CV) | 3.47±2.01 | 6.11±2.17 | 5.48±2.58 | 15.28±8.69 |
LM (CV) | 0.41±0.17 | 2.51±1.49 | 0.42±0.25 | 2.75 ±1.93 |
BMC (CV) | 1.70±1.08 | NA | 2.47±2.11 | NA |
| ||||
High-weight (n=10) | ||||
FM (CV) | 2.54±1.61 | 8.29±4.29 | 3.17±2.58 | 8.29±4.29 |
LM (CV) | 0.38±0.15 | 2.91±1.49 | 0.44±0.21 | 2.66±1.70 |
BMC (CV) | 1.86±0.89 | NA | 2.47±2.11 | NA |
The data is presented as the mean±standard deviation.
RE, euthanasia with repositioning; RA, anesthesia with repositioning; DXA, dual energy X-ray absorptiometry; NMR, nuclear magnetic resonance; FM, fat mass; CV, coefficient of variation; LM, lean mass; BMC, bone mineral content; NA, not applicable.